Literature DB >> 32005084

Racial/Ethnic and Gender Differences in Associations of Medication-Assisted Therapy and Reduced Opioid Use between Outpatient Treatment Admission and Discharge.

George Pro1, Jeff Utter2, Jessica Cram3, Julie Baldwin1,4.   

Abstract

Medication-assisted therapy (MAT) for opioid use disorders is an effective treatment strategy. Racial/ethnic and gender disparities in MAT utilization have been documented, but less is known about disparities in MAT outcomes. We used the Treatment Episodes Dataset-Discharges (TEDS-D; 2015- 2017) to identify outpatient treatment episodes with heroin or illicit opioids indicated at admission (n = 232,547). We used multivariate logistic regression to model the association between MAT and a reduction in opioid use between treatment admission and discharge. We explored moderation by race/ethnicity and gender by including an interaction term. We identified a strong moderating effect of race/ethnicity and gender. American Indian/Alaska Native (AI/AN) women demonstrated the strongest association between MAT (versus no MAT) and a reduction in opioid use (aOR = 6.05, 95% CI = 4.81- 7.61), while White men demonstrated the weakest association (aOR = 2.78, CI = 2.70- 2.87). Our findings could inform changes in clinical MAT settings that are based on harm reduction and the incremental transition from illicit opioids to medication-assistance among a diverse opioid use disorder population.

Entities:  

Keywords:  Health disparities; medication-assisted therapy; opioids

Mesh:

Year:  2020        PMID: 32005084     DOI: 10.1080/02791072.2020.1717685

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  3 in total

Review 1.  An Evaluation of Opioid Use in Black Communities: A Rapid Review of the Literature.

Authors:  Ayana Jordan; Myra Mathis; Angela Haeny; Melissa Funaro; Dafna Paltin; Yusuf Ransome
Journal:  Harv Rev Psychiatry       Date:  2021 Mar-Apr 01       Impact factor: 3.732

2.  Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.

Authors:  George Pro; Brooke E E Montgomery; Nickolas Zaller
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-19

3.  Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review.

Authors:  Tessa Nalven; Nichea S Spillane; Melissa R Schick; Lisa L Weyandt
Journal:  Exp Clin Psychopharmacol       Date:  2021-07-05       Impact factor: 3.492

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.